Latest Ratios: P/E Ratio 54.0x · EV/EBITDA 14.8x · ROE 3.5%. (2015–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $1.6B | $2.1B | $831M | $1.6B | $3.1B | $4.6B | $3.7B | $2.6B | $2.2B | $2.5B | — |
| Enterprise Value | $2.3B | $2.7B | $1.6B | $2.4B | $3.9B | $5.3B | $4.4B | $3.6B | $2.8B | $3.1B | — |
| P/E Ratio → | 53.97 | 70.14 | — | — | 74.54 | 33.56 | 102.93 | 81.07 | 93.90 | 58.01 | — |
| P/S Ratio | 0.81 | 1.05 | 0.46 | 0.77 | 1.89 | 2.22 | 2.19 | 1.54 | 1.45 | 1.83 | — |
| P/B Ratio | 1.85 | 2.40 | 1.02 | 1.98 | 3.45 | 4.98 | 4.14 | 3.41 | 3.00 | 3.82 | — |
| P/FCF | 21.78 | 28.47 | 21.78 | 28.13 | 550.76 | 28.23 | 23.71 | 41.55 | 1042.90 | — | — |
| P/OCF | 10.94 | 14.29 | 6.22 | 9.47 | 26.11 | 17.82 | 15.96 | 16.05 | 20.88 | 27.91 | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 1.38 | 0.86 | 1.13 | 2.36 | 2.54 | 2.58 | 2.07 | 1.81 | 2.24 | — |
| EV / EBITDA | 14.80 | 18.02 | 17.73 | 46.91 | 24.48 | 19.08 | 24.75 | 22.16 | 23.89 | 23.87 | — |
| EV / EBIT | 36.82 | 44.84 | — | — | 73.64 | 30.19 | 50.81 | 55.86 | 66.13 | 51.61 | — |
| EV / FCF | — | 37.40 | 41.23 | 41.41 | 687.62 | 32.31 | 27.95 | 55.89 | 1305.65 | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 54.2% | 54.2% | 58.1% | 52.9% | 59.4% | 56.5% | 54.0% | 53.2% | 53.6% | 53.7% | 54.5% |
| Operating Margin | 3.1% | 3.1% | -0.6% | -2.2% | 3.2% | 8.4% | 5.1% | 4.3% | 2.8% | 4.9% | 5.5% |
| Net Profit Margin | 1.5% | 1.5% | -1.6% | -3.1% | 2.6% | 6.2% | 2.1% | 1.9% | 1.5% | 3.3% | 1.2% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 3.5% | 3.5% | -3.5% | -7.6% | 4.6% | 14.0% | 4.3% | 4.3% | 3.4% | 8.6% | 3.7% |
| ROA | 1.4% | 1.4% | -1.4% | -3.0% | 1.8% | 5.5% | 1.7% | 1.8% | 1.5% | 2.9% | 1.0% |
| ROIC | 3.0% | 3.0% | -0.5% | -2.1% | 2.4% | 8.3% | 4.0% | 3.7% | 2.5% | 4.3% | 4.4% |
| ROCE | 3.8% | 3.8% | -0.6% | -2.5% | 2.7% | 8.8% | 4.6% | 4.6% | 3.0% | 5.0% | 5.0% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.80 | 0.80 | 1.00 | 1.11 | 1.11 | 1.05 | 1.15 | 1.23 | 0.78 | 0.86 | 1.86 |
| Debt / EBITDA | 4.56 | 4.56 | 9.20 | 17.95 | 6.32 | 3.52 | 5.85 | 5.93 | 4.95 | 4.41 | 6.30 |
| Net Debt / Equity | — | 0.75 | 0.91 | 0.93 | 0.86 | 0.72 | 0.74 | 1.18 | 0.75 | 0.86 | 1.84 |
| Net Debt / EBITDA | 4.30 | 4.30 | 8.36 | 15.04 | 4.87 | 2.41 | 3.76 | 5.68 | 4.81 | 4.37 | 6.26 |
| Debt / FCF | — | 8.93 | 19.45 | 13.27 | 136.86 | 4.08 | 4.24 | 14.34 | 262.75 | — | 97.95 |
| Interest Coverage | 3.62 | 3.62 | -0.59 | -3.15 | 114.21 | 6.83 | 1.80 | 1.92 | 1.12 | 1.00 | 1.70 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.55 | 0.55 | 0.53 | 1.00 | 1.38 | 1.50 | 1.72 | 0.86 | 1.01 | 0.77 | 0.74 |
| Quick Ratio | 0.33 | 0.33 | 0.33 | 0.70 | 1.02 | 1.14 | 1.39 | 0.39 | 0.47 | 0.34 | 0.30 |
| Cash Ratio | 0.09 | 0.09 | 0.16 | 0.38 | 0.67 | 0.89 | 1.14 | 0.14 | 0.08 | 0.02 | 0.02 |
| Asset Turnover | — | 0.93 | 0.91 | 0.98 | 0.72 | 0.91 | 0.73 | 0.85 | 0.93 | 0.87 | 0.78 |
| Inventory Turnover | 10.20 | 10.20 | 8.14 | 8.35 | 5.42 | 7.32 | 7.07 | 6.32 | 6.15 | 6.99 | 6.26 |
| Days Sales Outstanding | — | 10.53 | 10.00 | 14.91 | 17.73 | 9.78 | 12.37 | 9.41 | 12.05 | 11.46 | 10.49 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | 6.8% | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | 373.2% | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 1.9% | 1.4% | — | — | 1.3% | 3.0% | 1.0% | 1.2% | 1.1% | 1.7% | — |
| FCF Yield | 4.6% | 3.5% | 4.6% | 3.6% | 0.2% | 3.5% | 4.2% | 2.4% | 0.1% | — | — |
| Buyback Yield | 0.2% | 0.2% | 0.4% | 1.7% | 2.7% | 1.6% | 0.0% | 1.0% | 0.1% | 0.0% | — |
| Total Shareholder Yield | 0.2% | 0.2% | 0.4% | 1.7% | 2.7% | 1.6% | 0.0% | 1.0% | 0.1% | 6.8% | — |
| Shares Outstanding | — | $81M | $79M | $78M | $80M | $96M | $83M | $82M | $79M | $62M | $72M |
Optometrist labor supply constraints
According to current market data, EYE trades at a forward P/E of 26.93, which appears elevated relative to its historical profitability and suggests that investors are pricing in a significant recovery in operating margins that may not materialize given the ongoing structural transition away from legacy partnerships.
The valuation premium relative to the company's thin net margins implies an expectation of future operating leverage that remains unproven in the current data. Investors should monitor whether the P/E contraction reflects a realistic reassessment of the company's growth ceiling rather than a temporary market mispricing.
Based on reported financial figures, the company's ROIC has struggled to gain traction, hovering at a modest 2.2% in 2026Q1, which indicates that the firm is currently failing to generate returns on invested capital that meaningfully exceed its likely cost of capital in this high-rate environment.
The persistent low ROIC suggests that the heavy capital intensity required to maintain the physical store footprint and lab infrastructure is not yet yielding the expected compounding effect. This trend warrants further investigation into whether the current store maturation cycle can eventually drive returns toward a more sustainable level.
As reported in recent quarterly filings, the cash conversion cycle has fluctuated between 14 and 40 days over the last ten quarters, reflecting inconsistent management of inventory and payables as the company navigates the wind-down of its legacy segment and shifts its operational focus toward owned brands.
The volatility in the CCC suggests that the company's working capital efficiency is highly sensitive to supply chain timing and the integration of new store formats. Analysts should interpret the recent compression in the CCC as a potential sign of improved inventory management, though it remains vulnerable to future disruptions.
According to the latest balance sheet data, the current ratio has deteriorated to 0.62 as of 2026Q1, a significant decline from the 1.01 level observed in 2024Q1, which indicates that the company's short-term liquidity position has become increasingly reliant on operational cash flow to meet immediate obligations.
This tightening liquidity profile suggests that the company has limited room for error should a cyclical downturn impact retail traffic. The reliance on cash flow to cover current liabilities warrants close monitoring, as any further contraction in the quick ratio could signal heightened refinancing risk in the near term.
Investors frequently misapply standard P/S multiples to National Vision, failing to account for the fact that the company functions more as a medical services funnel than a traditional retailer, which obscures the structural bottleneck created by the mandatory, labor-intensive eye exam requirement for every retail sale.
Using a standard retail P/S multiple ignores the unique cost structure associated with professional optometric labor, which acts as a hard cap on revenue growth. A more appropriate metric would be an EV/Exam-Capacity ratio, which better captures the true operational constraint of the business model.
Includes 30+ ratios · 11 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying EYE stock.
National Vision Holdings, Inc.'s current P/E ratio is 54.0x. The historical average is 73.5x. This places it at the 14th percentile of its historical range.
National Vision Holdings, Inc.'s current EV/EBITDA is 14.8x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 24.5x.
National Vision Holdings, Inc.'s return on equity (ROE) is 3.5%. The historical average is 3.3%.
Based on historical data, National Vision Holdings, Inc. is trading at a P/E of 54.0x. This is at the 14th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
National Vision Holdings, Inc. has 54.2% gross margin and 3.1% operating margin.
National Vision Holdings, Inc.'s Debt/EBITDA ratio is 4.6x, indicating high leverage. A ratio above 4x may signal elevated financial risk.